Piper Sandler Downgrades Danimer Scientific to Neutral, Lowers Price Target to $1.25
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Charles Neivert downgraded Danimer Scientific (DNMR) from Overweight to Neutral and reduced the price target from $3.5 to $1.25.
April 09, 2024 | 10:44 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Piper Sandler downgraded Danimer Scientific to Neutral and lowered its price target to $1.25.
The downgrade from Overweight to Neutral by a prominent analyst, along with a significant reduction in the price target, is likely to negatively impact investor sentiment and could lead to a short-term decrease in DNMR's stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100